- Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
-
Pak ES, Cha JJ, Cha DR, Kanasaki K, Ha H
- KMID: 2535414
- Kidney Res Clin Pract.
- 2022 Sep;41(Suppl 2):S74-S88.
- doi: 10.23876/j.krcp.22.011
Diabetic kidney disease (DKD) is now a pandemic worldwide, and novel therapeutic options are urgently required. Adenosine, an adenosine triphosphate metabolite, plays a role in kidney homeostasis through interacting with... -
- CITED
-
- Close
- SHARE
-
- Close
